Interferon-induced transmembrane proteins (IFITM) are restriction factors that inhibit the 26 infectious entry of many enveloped RNA viruses. However, we demonstrated previously that 27 human IFITM2 and IFITM3 are essential host factors facilitating the entry of human coronavirus 28 (HCoV)-OC43. In a continuing effort to decipher the molecular mechanism underlying IFITM 29 differential modulation of HCoV entry, we investigated the role of structural motifs important for 30 IFITM protein post-translational modifications, intracellular trafficking and oligomerization in 31 modulating the entry of five HCoVs. We found that three distinct mutations in IFITM1 or 32 IFITM3 converted the host restriction factors to enhance the entry driven by the spike proteins of 33 severe acute respiratory syndrome coronavirus (SARS-CoV) and/or Middle East respiratory 34 syndrome coronavirus (MERS-CoV). First, substitution of IFITM3 tyrosine 20 with either 35 alanine or aspartic acid to mimic the unphosphorylated or phosphorylated IFITM3 reduced its 36 activity to inhibit the entry of HCoV-NL63 and 229E, but enhanced the entry of SARS-CoV and 37 MERS-CoV. Second, substitution of IFITM3 tyrosine 99 with either alanine or aspartic acid 38 reduced its activity to inhibit the entry of HCoV-NL63 and SARS-CoV, but promoted the entry 39 of MERS-CoV. Third, deletion of carboxyl-terminal 12 amino acid residues from IFITM1 40 enhanced the entry of MERS-CoV and HCoV-OC43. These findings suggest that these residues 41 and structural motifs of IFITM proteins are key determinants for modulating the entry of HCoVs, 42 most possibly through interaction with viral and/or host cellular components at the site of viral 43 entry to modulate the fusion of viral envelope and cellular membranes. 44 on December 22, 2017 by FUDAN UNIVERSITY http://jvi.asm.org/ Downloaded from 57 58
Importance 45
46
The differential effects of IFITM proteins on the entry of HCoVs that utilize divergent entry 47 pathways and membrane fusion mechanisms even when using the same receptor make the 48 HCoVs a valuable system for comparative investigation of the molecular mechanisms underlying 49 IFITM restriction or promotion of virus entry into host cells. Identification of three distinct 50 mutations that converted IFITM1 or IFITM3 from inhibitors to enhancers of MERS-CoV or 51 SARS-CoV spike protein mediated entry reveals key structural motifs or residues determining 52 the biological activities of IFITM proteins. These findings have thus paved a way for further 53 identification of viral and host factors that interact with those structural motifs of IFITM proteins 54 to differentially modulate the infectious entry of HCoVs. 55 56 on December 22, 2017 by FUDAN UNIVERSITY http://jvi.asm.org/ Downloaded from INTRODUCTION Concerning the molecular mechanism underlying IFITM restriction of virus entry, the 80 currently favored hypothesis postulates that existence of IFITM proteins in the endocytic 81 membranes either alters the membrane curvature or fluidity to make the endosomal membrane 82 rigid and harder to fuse with viral envelopes (24, 25) (26-28) . However, several recent findings 83 challenge this hypothesis. First, human IFITM2 and IFITM3 efficiently enhance the infectious 84 entry of HCoV-OC43 via a post receptor binding/endocytosis mechanism (29). Second, mutation 85 of the SVKS motif in the CD225 domain required for IFITM1 to inhibit HIV-1 entry and 86 IFITM3 to restrict IAV and dengue virus infection (24, 30) enhances Lloviu virus (LLOV) 87 glycoprotein-mediated entry ( Fig. 11) (31) . Third, human IFITM proteins are required for the 88 formation of human cytomegalovirus virion assembly complex (VAC) and infectious virion 89 secretion (32). The VAC is a perinuclear membrane structure where the vesicles with endosomal 90 markers occupy the central area and the vesicles with the Golgi markers are wrapped around it to 91 form a circle (33) . It is possible that IFITMs modulate endosomal trafficking/fusion during the 92 VAC formation. All those findings strongly suggest that the IFITM-induced membrane curvature 93 and/or fluidity alterations may not always make the endocytic membranes too "rigid" to fuse, but 94 at least under certain condition, may facilitate membrane fusion. 95
In order to further understand the molecular mechanism underlying the differential 96 modulation of IFITM proteins on HCoV entry, we set out to identify structural motifs important 97 for IFITM protein post-translational modifications, intracellular trafficking and oligomerization 98 in modulating the entry of five HCoVs. We found that although both SARS-CoV and NL63 use 99 angiotensin-converting enzyme 2 (ACE2) as their entry receptor, IFITMs differentially modulate 100 the entry of these two viruses. We also found that three distinct mutations in IFITM1 or IFITM3 101 7 (S) of HCoV-229E (229Epp), HCoV-NL63 (NL63pp), SARS-CoV (SARSpp) and in both HEK293 (Fig.1B) and Huh7.5 cells (Fig. 1C ). However, comparing the extent 127 of IFITM inhibition between the two cell lines (Figs. 1B and C) , IFITM2 and IFITM3 inhibition 128 of IAVpp infection was 4-and 20-fold more potent, respectively, in HEK293 cells than that in 129 Huh7.5 cells. On the contrary, IFITM2 and IFITM3 more efficiently inhibited entry of all four 130 HCoVpp, particularly for MERSpp and 229Epp, in Huh7.5 cells. The steady state levels of 131 IFITM1 were lower than that of IFITM2 and IFITM3 in both HEK293 and Huh7.5 cells, which 132 may, at least in part, explain its lower activity to inhibit the infection of all the tested 133 pseudoviruses, except for 229Epp. Interestingly, IFITM1 more potently inhibited 229Epp 134 infection than IFITM2/3 in HEK293 cells, but was less effective in Huh7.5 cells. While the viral 135 envelope proteins are obviously the primary determinants of the potency of IFITMs to restrict 136 virus entry, the more potent inhibition by all three IFITMs on the infection of NL63pp than that 137 of SARSpp suggests that host cellular factors other than viral receptors have a strong impact on 138 antiviral activity of IFITMs. 139 140 Substitution of Y20 in IFITM3 enhances SARS-CoV and MERS-CoV entry. We next aimed 141 at identifying IFITM structural motifs that control the modulation of HCoV entry. IFITM 142 proteins contain a conserved CD225 domain flanked by sequence-divergent N-and C-terminal 143 variable regions (5) . The N-terminal 21 amino acid residues unique to IFITM2 or 3 has been 144 demonstrated to be important for IFITM3 to inhibit IAV infection in cultured cells and in vivo in 145 humans (35) (36) (37) (38) . It has been shown recently that the N-terminal region of IFITM3 contains a 20-146 YEML-23 tetrapeptide that is consistent with the canonical YxxΦ endocytic sorting signal (x can 147 be any amino acid, Φ denotes Val, Leu, or Ile) (39-41). Furthermore, the Y20 can be 148 on December 22, 2017 by FUDAN UNIVERSITY http://jvi.asm.org/ Downloaded from phosphorylated by tyrosine kinase Fyn, which regulates the IFITM3 trafficking and metabolism 149 (42). We thus investigated how the phosphorylation of IFITM3 at Y20 may regulate its function 150 of modulating HCoV entry. The results showed that compared to wild-type IFITM3, substitution 151 of Y20 with alanine (A) and aspartic acid (D) or glutamic acid (E) to mimic the non-152 phosphorylated (Y20A) or phosphorylated (Y20E or Y20D) IFITM3, respectively, did not alter 153 the steady-state levels of expression (Figs. 2A and F) and activity to enhance the entry of . However, the mutant IFITM3 155 proteins showed significantly reduced activity to inhibit NL63pp and 229Epp infection (Figs. 2C, 156 D, H and I) . On the contrary, mutant IFITM3 proteins enhanced the infection of SARSpp and 157
MERSpp in both cell lines (Figs. 2C, E, H and J) . Consistent with previous reports (39, 40) , 158 wild-type IFITM3 was accumulated in the perinuclear region and primarily co-localized with 159
Rab9, a later endosome marker (43) (Fig. 3A) . In contrast, IFITM3 proteins bearing Y20A or 160 Y20D mutation were primarily accumulated in the regions closed to the plasma membrane (Fig. 161 3B and 3C). These results indicate that Y20 is critical for endocytic sorting, which is regulated 162 by tyrosine phosphorylation. 163
In order to investigate whether the enhanced infection of SARSpp and MERSpp by the 164 mutant IFITM3 proteins is due to the induction of membrane fusion on the plasma membrane, 165
we examined the effect of endosomal pH on HCoVpp infection of Huh7.5 cells expressing wild-166 type or Y20A IFITM3 (Fig. 4) The results thus suggest that although Y20 mutant IFITM3 proteins are primarily accumulated in 172 the plasma membrane regions, the enhanced infection of SARSpp and MERSpp still occurs in 173 low pH endosomal compartments. 174 175 Substitution of Y99 in IFITM3 enhances MERS-CoV entry. In addition to Y20, Y99 had 176 been shown to be phosphorylated in cells by mass spectrometry analysis and play a role in 177 restricting the infectious entry of IAV, but not dengue virus (24). Therefore, we performed 178 phosphomimetic analysis on this amino acid residue. As shown in Fig. 5A , the Y99A or Y99D 179 mutant IFITM3 was expressed to a level similar to that of wild-type IFITM3. Compared with 180 wild-type IFITM3, Y99A or Y99D mutants had a slightly increased activity to enhance OC43pp previously that sequential truncation of the C-terminal 18 amino acid residues from IFITM1 did 208 not apparently affect its activity to inhibit the infection of IAVpp, but converted the antiviral 209 protein to an increasingly potent enhancer of OC43pp infection (29). In our efforts toward 210 further dissecting the role of C-terminal domain (CTD) in IFITM1 modulation of HCoV entry, 211 we found that deletion of C-terminal 3, 6 or 9 amino acids did not apparently affect the activity 212 of IFITM1 to inhibit the infection of SARSpp, but further deletion of C-terminal 12, 15 or 18 213 amino acids significantly compromised or abolished the ability of IFITM1 to inhibit the infection 214 of SARSpp (Fig. 7B ). In contrast, deletion of C-terminal 3, 6 and 9 amino acids enhanced the 215 effect on NL63pp infection ( Fig. 7B ). Interestingly, sequential truncation of the CTD gradually 218 attenuated and ultimately abolished the activity of IFITM1 to inhibit 229Epp infection ( Fig. 7C) . 219
On the contrary, sequential truncation of C-terminal 12 amino acids gradually increased its 220 activity to enhance MERSpp infection, but further deletion of C-terminal 15 or 18 amino acids 221 reduced its activity to enhance MERSpp infection ( Fig. 7D) . 222
To rule out the potential interference of endogenous IFITM proteins on mutant IFITM1 223 in HEK 293 cells (29) NL63pp infection, we also observed that deletion of C-terminal 6, but not 18, amino acids 231 significantly increased the ability of IFITM1 to inhibit the infection of HCoV-NL63, as judged 232 by significant reduction in infected cell percentage and intracellular viral RNA (Figs. 8C and D) . 233
Taken together, the results suggest that two partially overlapped functional motifs exist in 234 the CTD of IFITM1. While its C-terminal 9 to 12 amino acid residues contain a motif that down-235 regulates the antiviral activity against HCoV-NL63 and suppresses the enhancing activity to 236 MERS-CoV infection, the motif located in the N-terminal 9 amino acid residues of the CTD is 237 important for IFITM1 to suppress SARS-CoV and HCoV-229E entry. 238
To investigate the molecular mechanisms underlying the differential modulation of 239
HCoV entry by the CTD, we examined the subcellular localization of wild-type and mutant 240 on December 22, 2017 by FUDAN UNIVERSITY http://jvi.asm.org/ Downloaded from IFITM1 proteins. As shown in Fig.9 , similar to wild-type IFITM1, IFITM1/TC6 and 241 IFITM1/TC18 are primarily accumulated in regions close to or at the plasma membrane. 242 However, a modestly increased intracellular localization of both IFITM1/TC6 and IFITM1/TC18 243 is evident. Specifically, IFITM1/TC6 tends to more frequently co-localize with Rab5 and Rab9, 244 whereas IFITM1/TC18 is more frequently co-localized with EEA1, an early endosomal marker 245 (48), and Rab9, a later endosomal marker. Moreover, as shown in Fig. 10 , compared to wild-type 246 IFITM1, IFITM1/TC6, but not IFITM1/C18, demonstrated reduced mono-and di-ubiquitination. 247
As anticipated, substitution of four residues of lysine in IFITM3 (IFITM3/4KA) completely 248 abolished ubiquitination. The results thus indicate that the CTD of IFITM1 contains structural 249 motif(s) that regulates its subcellular trafficking and ubiquitination, which may consequentially 250 affect its activity to modulate the entry of HCoVs. as all the DNA viruses tested thus far (6, 8, 49, 50) . The molecular determinants that control the 257 viral specificity and potency of IFITMs remain to be fully understood. Because viral envelope 258 proteins and cellular receptors are the two major players of viral membrane fusion, it is plausible 259 to consider that modulating the interaction between viral envelope proteins and cellular receptors 260 might be the key mechanism of IFITM restriction of virus entry. Indeed, it was reported recently 261 that IFITM sensitivity of HIV-1 strains is determined by the co-receptor usage of viral envelope 262 glycoproteins (51, 52). However, the difference in the potency and requirement of IFITM the results that IFITM3/Y20 phosphomimetic mutations only enhanced the infection of SARSpp, 265 but not NL63pp (Fig. 2 ) strongly suggest that IFITM interaction with viral and host cellular 266 factors, other than viral receptors, such as ACE2, play a critical role in IFITM modulation of 267 virus entry. Furthermore, our findings that IFITM2 and IFITM3 promoted HCoV-OC43 268 infection, and three distinct mutations converted IFITM1 or IFITM3 from inhibitors to enhancers 269 of SARS-CoV and/or MERS-CoV spike protein-mediated entry challenge the "rigid" membrane 270 hypothesis and suggest that IFITM proteins may also promote the membrane fusion, under 271 selected conditions, to facilitate virus entry. 272
Based on those new findings, we hypothesize that depending on the fine-tuned interaction 273 with the entry machinery of a given virus, which consists of viral envelope components as well 274 as viral receptors and other host entry factors at the site of membrane fusion, IFITM proteins can 275 either promote or arrest the fusion between viral envelope and endosomal membranes (29). It is 276 possible that the three structural motifs identified herein mediate interactions with key host 277 factors to determine either to arrest or to enhance the membrane fusion. Along this line, recent 278 studies revealed that zinc metallopeptidase STE24 forms complexes with IFITM proteins and is 279 required for IFITMs to inhibit the entry of many different viruses (53). In addition, the sensitivity 280 of IAVs to IFITM3 appears to depend on the pH value at which the viral HA undergoes a 281 conformational transition and mediates membrane fusion (54) Our new hypothesis predicts that in order to modulate virus entry, IFITM proteins ought 289 to be at the site of viral membrane fusion (26) (27) (28) . Indeed, previous studies demonstrated in a 290 variety of virus infection systems that localization at the subcellular compartment where a virus 291 enters into the cytoplasm is important for the IFITM protein to inhibit its infectious entry (5). For 292 instance, disruption of the canonical endocytic signal in IFITM3 by Y20A/E/D mutations 293 resulted in its plasma membrane accumulation ( Fig. 11 ). As a consequence, the mutant IFITM3 294 demonstrated a reduced antiviral activity against IAV that enter cells by fusion with lysosomal 295 membrane (39-41), but enhanced the activity to restrict the infection of parainfluenza virus 3, a 296 virus that enters cells by fusion with the plasma membrane (56). However, the subcellular 297 localization of IFITM proteins is not always strictly correlated with antiviral activity. For 298 example, while IFITM3 Y99A mutation does not apparently alter the subcellular localization, the 299 mutation significantly compromises the antiviral activity of IFITM3 against IAV, but not dengue 300 virus (24). In this study, we further demonstrated that although Y20A mutant IFITM3 was 301 predominantly accumulated in the plasma membrane regions, its enhanced infection of SARSpp, 302
MERSpp and OC43pp was still low pH dependent ( Fig. 4 ) (29), suggesting that the enhanced 303 entry of those viruses still occurs in low pH intracellular endosomal compartments. The apparent 304 contradiction between the subcellular localization of the mutant IFITM3 proteins and site of 305 membrane fusion implies that a small fraction of the mutant IFITM3 might still traffic to the sites 306
where the viral spike protein-induced membrane fusion occurs. In addition, phosphomimetic 307 analyses suggest that Y20 or Y99 tyrosine phosphorylation regulates the metabolism, trafficking 308 and biological function of IFITM3. 309 on December 22, 2017 by FUDAN UNIVERSITY http://jvi.asm.org/
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In addition to tyrosine phosphorylation, IFITM3 can also be post-translationally modified 310 at more than 8 different amino acid residues with at least three different types of modifications, 311 including palmitoylation, ubiquitination and methylation (42, (44) (45) (46) (47) 57) . Our mutagenesis 312 studies showed that both palmitoylation and ubiquitination are absolutely required for IFITM3 to 313 modulate the entry of all the tested HCoVs (Fig. 6) . Moreover, oligomerization of IFITM 314 proteins has been demonstrated to be essential for their restriction of IAV and dengue virus 315 infection as well as enhancement of HCoV-OC43 infection (24, 29) . Interestingly, hetero-316 oligomerization between IFITM1 and IFITM3, that inhibits and enhances HCoV-OC43 infection, 317 respectively, antagonize each other's functions (29) . In this study, we further revealed that 318 IFITM3 bearing F75A and F78A mutations that disrupt its oligomerization completely lost its 319 ability to inhibit the infection of SASRpp, 229Epp and MERSpp, but still partially inhibited 320
NL63pp infection ( Figs. 6 and 11 ). While the results reinforce the notion that oligomerization is 321 important for IFITMs to modulate the entry of many viruses, NL63 appears to be an exception. 322
It was reported previously that the CTD of IFITM1, illustrated in Fig. 11 , plays an 323 important role in modulating the entry of HCoV-OC43 (29), HIV1 (58), jaagsiekte sheep 324 retrovirus and 10A1 amphotropic murine leukemia virus (59). In this study, we showed that the 325 CTD of IFITM1 plays distinct roles in modulating the entry of different HCoVs. It appears that 326 the CTD contains two overlapping functional motifs. While the C-terminal 9 and 12 amino acid 327 residues negatively regulate IFITM restriction of HCoV-NL63 entry and enhancement of MERS-328 COV infection, the motif located in the N-terminal 9 amino acid residues of the CTD is 329 important for IFITM1 to suppress SARS-CoV and HCoV-229E entry. In search for the 330 underlined mechanism, a study identified a dibasic 122 KRxx 125 motif at the C-terminus of 331 IFITM1 regulates IFITM1 intracellular trafficking with reduced localization in LAMP1-positive 332 on December 22, 2017 by FUDAN UNIVERSITY http://jvi.asm.org/ Downloaded from lysosomes, but increased levels in CD63-positive multivesicular bodies (59). IFITM1 binds to 333 cellular adaptor protein complex 3 (AP-3), an association that is lost when the dibasic motif is 334 altered (59). However, we found that partial or complete deletion of the CTD does not 335 dramatically alter its subcellular distribution (Fig. 9) . Instead, deletion of 6, but not 18 amino 336 acid residues from the C-terminus reduced IFITM1 ubiquitination (Fig. 10) . The results 337 collectively indicate that the CTD is a key regulator of IFITM function. However, its effects on 338 the entry of different viruses imply a versatile function of the CTD. Further investigation into the 339 structure, post-translational modification and membrane topology of the CTD as well as 340 identification of the cellular and/or viral proteins interacting with the CTD will shed light on the 341 mechanism by which the CTD regulates the function of IFITM1. 342
In summary, we demonstrated in this study that in addition to viral envelope proteins and 343 cellular receptors, IFITM protein oligomerization, post-translational modification and 344 intracellular trafficking, which can be regulated by host cellular pathobiological cues, play 345 critical roles in determining the extent and nature of IFITMs to modulate the entry of HCoVs. 346
More importantly, identification of the three structural motifs that reverse the function of 347 IFITM1 and IFITM3 on virus entry paves the way for uncovering viral and host factors that 348 interact with those structural motifs to differentially modulate the infectious entry of HCoVs and 349 other viruses (53). N-terminally FLAG-tagged human IFITM1, IFITM2 and IFITM3 as well as C-terminally 373 truncated IFITM1 mutants were reported previously (7, 60, 61) (29). Plasmids expressing N-374 terminally FLAG-tagged mutant IFITM3 proteins with point mutations were constructed by 375 overlap extension PCR (60). All resulting plasmids were sequenced to verify the desired 376 mutation(s). N-terminally FLAG-tagged human IFITM1, IFITM2 and IFITM3 and their mutants 377 were also cloned into pQCXIP vector (Clontech) between the NotI and BamHI sites (29). PlanApoN 60×/1.42 N objective (Olympus). Pinhole size was adjusted to 1 airy unit. Optimal 448 diffraction-limited spatial resolution was obtained using a pixel size of 82 nm /pixel. DAPI was 449 excited at 405 nm and its fluorescence emission collected between 430 nm and 470 nm. Alexa 450
Fluor 488 was excited at 488nm and its fluorescence emission collected between 505 and 525 451 nm. Alexa Fluor 594 was excited at 543nm and its fluorescence emission collected between 560 452 and 660 nm. Negative controls were performed to make sure that there were no significant 453 spectral bleed-through artifacts between channels. 454 455 TCID 50 . Confluent LLC-MK2 cells cultured in 96-well plates were infected with 200 µl of 456 OPTI-MEM containing a serial 10-fold dilution of viral stock for 2 h at 33 °C. Cells were then 457 cultured at 33 °C with MEM with 2.5% FBS for 6 days. The cells of each well with cytopathic 458 effect (CPE) were visualized and counted under microscope. The TCID 50 of virus stock was 459 measured and converted to pfu/ml (68). 460
461
Immunoprecipitation To detect ubiquitination of IFITM protein and its mutants, IP-western 462 blot was performed as reported previously (29, 44) . Briefly, 293T cells were transfected with 463 plasmids expressing FLAG-tagged IFITM1, IFITM3 and their mutants, respectively. Cells were 464 lysed at 48 h post transfection with lysis buffer containing 50 mM Tris-HCl (pH 7.4), 150 mM 465 NaCl, 1 mM EDTA, and 1% Triton X-100 and protease inhibitors (Roche) and 466 immunoprecipitated with a monoclonal antibody against FLAG epitope followed by incubation 467 are indicated. IMD and CIL domains comprise the canonical CD225 domain (shown in red). 818 20 YXXФ 23 motif required for IFITM3 endocytosis and 122 KRXX 125 motif that serves as a sorting 819 signal for IFITM1 are underlined with purple lines. The putative phosphorylation, palmitoylation 820 and ubiquitination sites are indicated. Two phenylalanine residues in the IMD that promote 821 IFITM oligomerization are indicated with red up-triangles. 822
